PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China flag China · Delayed Price · Currency is CNY
37.02
-0.39 (-1.04%)
May 20, 2026, 12:14 PM CST
Market Cap8.72B +46.3%
Revenue (ttm)2.03B +14.8%
Net Income196.83M -4.4%
EPS0.91 -12.1%
Shares Out232.97M
PE Ratio41.30
Forward PE37.41
Dividend0.28 (0.75%)
Ex-Dividend DateMay 30, 2025
Volume3,944,920
Average Volume9,232,472
Open38.00
Previous Close37.41
Day's Range36.52 - 38.00
52-Week Range31.11 - 53.54
Beta0.64
RSI43.56
Earnings DateApr 22, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small... [Read more]

Sector Healthcare
Founded 2006
Employees 2,593
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300725
Full Company Profile

Financial Performance

In 2025, SHE:300725's revenue was 1.97 billion, an increase of 16.93% compared to the previous year's 1.69 billion. Earnings were 183.74 million, a decrease of -16.31%.

Financial Statements